Reference number : 236-2017-2018-Q4-00378, amendment number : , agreement type : G, recipient legal name : Field, Thalia S, recipient country : CA, recipient province : BC, recipient city : Vancouver, recipient postal code : V6T 1Z1, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 40000.0, agreement start date : 2018-03-01, agreement end date : 2019-02-28, description english : EmPOwER: Engaging Persons with cerebral venous thrombosis for meaningful Outcomes and peER support: A patient engagement initiative of the SECRET (Study of rivaroxaban for CeREbral venous Thrombosis) Trial, description french : EmPOwER: Engaging Persons with cerebral venous thrombosis for meaningful Outcomes and peER support: A patient engagement initiative of the SECRET (Study of rivaroxaban for CeREbral venous Thrombosis) Trial, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2017-18 to 2018-19), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2017-18 à 2018-19), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada